NEW YORK (GenomeWeb News) – Axela today announced that it has acquired Xceed Molecular for an undisclosed sum.

The deal combined Axela's multiplex protein biomarker testing capabilities with Xceed's Ziplex System for gene expression analysis. Axela said that the new firm, which will operate under its name, will offer clinical researchers a portfolio of products for analysis of proteins, pathogens, DNA, and RNA to speed the validation and clinical application of biomarkers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Vivek Murthy is no longer the surgeon general of the US, the Associated Press reports.

People around the globe took to the streets to support science — some with signs.

Parents who learn of their increased genetic risk of disease also contend with telling their children about theirs, the New York Times writes.

In PLOS this week: loci linked to body mass index measurements, long non-coding RNA expression and urothelial carcinoma prognosis, and more.